TARRIFF SCOTT (CEO) reported 1 transaction at EAGLE PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/24/2023ACC: 0001209191-23-004680
DirectorOfficer· CEO
Since Jun 2018
-3.73K
Net shares
Net seller
$125.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.73K
Price / share
$33.64
Trade value
$125.54K
% of position
0.2%
1/23/2023
1.58M→1.57M
Total
Net shares
−3.73K
Net value
-$125.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2023 | F · Tax Withholding | −3.73K | $33.64 | $125.54K | 0.2% | 1.58M | 1.57M |
| Total | −3.73K | -$125.54K | ||||||
Derivative Transactions0
No derivative transactions reported